Organic compounds -- part of the class 532-570 series inventions 09/08

20080234484 - Method for making tris (8-hydroxyquinoline) nano-crystal: A method for making a tris-(8-hydroxyquinoline) aluminum (Alq3) nano-crystals includes the steps of: (a) dissolving Alq3 powders into a solvent to form a solution A; (b) dissolving a surfactant in water to achieve a solution B; (c) uniformly mixing the solution A and the solution B to form a latex... Agent: PCe Industry, Inc. Att. Cheng-ju Chiang

20080234485 - 1-benzyl-4-[ (5,6-dimethoxy-1-indanon) -2-yl] methylpiperidine hydrobromide or crystals thereof: 1-Benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrobromide or a solvate thereof.... Agent: Birch Stewart Kolasch & Birch

20080234486 - Novel processes for the production of amorphous rabeprazole sodium: B

20080234487 - Substituted sulfoxide compounds, methods for preparing the same and use thereof: Disclosed are an optically pure compound having formula I, its pharmaceutically acceptable salt and its pharmaceutically acceptable solvate, and a use thereof in manufacturing medicaments and pharmaceutical compositions. A process for preparing the compound defined therein is also provided.... Agent: Mintz, Levin, Cohn, Ferris, Glovsky And Popeo, P.c Attn: Patent Intake Customer No. 30623

20080234488 - Method of deuteration using mixed catalyst: The subject of the present invention is to provide a method for deuteration, which can obtain a compound having an aromatic ring and/or a heterocyclic ring at an improved deuteration ratio. The present invention relates to a method for deuteration of a compound having an aromatic ring and/or a heterocyclic... Agent: Hamre, Schumann, Mueller & Larson, P.C.

20080227982 - Solvent free amorphous rapamycin: An improved process for coating implantable medical devices utilizes a number of techniques for improving the stability of therapeutic agents contained within the coating. The stability of the therapeutic agents may be improved by creating substantially solvent-free, amorphous forms of the therapeutic agents.... Agent: Philip S. Johnson Johnson & Johnson

20080227983 - Piperidine derivatives and process for their production: A process of preparing such piperidine derivative compounds in substantially pure form is also disclosed.... Agent: Heslin Rothenberg Farley & Mesiti PC

20080227984 - Selective oxidation of organic compounds: This invention relates to the selective oxidation of organic compounds. According to the invention organic compounds are selectively oxidized using a peracid or a source of peracid, a transition metal based heterogeneous catalysts and a borate or boric acid in the presence of water. Using the process of the present... Agent: Sheridan Ross PC

20080221328 - Luminescent lanthanide complexes: Neutral lanthanide(III) complexes including at least one ligand are disclosed. The ligand includes a heterocyclic aromatic ring with at least one carboxylic acid group attached thereto, wherein a heteroatom of the heterocyclic ring and the carboxylate function of the carboxylic acid group co-ordinate (chelate) to the lanthanide. The complexes can... Agent: Intellectual Property / Technology Law

20080221329 - Novel and economical process for preparing (s, s)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer: The present invention relates to a novel and economical process for preparing (S,S)-2, 8-diazabicyclo[4.3.0]nonane, a valuable intermediate used for constructing quinolone and naphthyridine derivatives having antibacterial effectiveness, e.g. moxifloxacin and its enantiomer.... Agent: Zheqing Wang

20080221330 - Mutilin-derivative substituted at position 12: (wherein R1 is a hydrogen atom, a formyl group, a substituted or unsubstituted lower alkyl group, an aralkyl group whose aromatic ring may be optionally substituted, a heteroaralkyl group whose aromatic ring may be optionally substituted or a lower alkyloxycarbonyl group; and R2 is a hydrogen atom, a lower alkyl... Agent: Wenderoth, Lind & Ponack, L.l.p.

20080221331 - Alcohol oxidation catalyst and its preparation process: h

20080221332 - Hindered amine salt compounds: wherein G1 and G2 are independently alkyl of 1 to 4 carbon atoms or are together pentamethylene; Z1 and Z2 are each methyl, or Z1 and Z2 together form an unsubstituted linking moiety or a linking moiety substituted by one or more groups selected from an ester, ether, hydroxy, oxo,... Agent: Joann Villamizar Ciba Corporation/patent Department

20080221333 - Process for preparing beta-ketoester compounds: The present invention relates to a process for preparing a beta-keto ester compound of formula (1), which is an intermediate for the synthesis of quinolone antibiotics. Particularly, the present invention is characterized by the reaction of an organo nitrile compound with a salt of mono-alkyl malonate in the presence of... Agent: Birch Stewart Kolasch & Birch

20080221334 - Process for the preparation of onium alkylsulfonates: The invention relates to a process for the preparation of onium alkylsulfonates by reaction of an onium halide or carboxylate with a symmetrically substituted dialkyl sulfite or with an asymmetrically substituted dialkyl sulfite at temperatures of 50 to 170° C.... Agent: Millen, White, Zelano & Branigan, P.c.

20080214817 - Process for preparing n-alkylnaltrexone halides: P

20080214818 - Organic metal complexes: wherein R1 includes hydrogen, C1˜C9 alkyl, C5˜C8 cycloalkyl, or substituted or non-substituted aromatic groups, R2 and R3 comprise hydrogen, fluorine, trifluoromethyl, C1˜C9 alkyl, C5˜C8 cycloalkyl, or substituted or non-substituted aromatic groups, Y comprises C—R or carbonyl, wherein R comprises hydrogen, C1˜C9 alkyl, C5˜C8 cycloalkyl, or substituted or non-substituted aromatic groups,... Agent: Birch Stewart Kolasch & Birch

20080214819 - Process of producing bleach boosters: This invention relates to a process of producing compounds, which are useful as bleach boosters, as well as to the compounds, which are obtainable using said process, and to their use.... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20080214820 - Enantiomers of 3-heteroaryl-8h-8-azabicyclo (3.2.1) oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors: i

20080214821 - Method of preparing clopidogrel and intermediates used therein: Optically pure clopidogrel can be prepared in a high yield by optically resolving a racemic form of the compound of formula (II) using an optically active amine to form the optically active form of the compound of formula (III) or its acid-addition salt; and methylating the compound of formula (III)... Agent: Sughrue Mion, PLLC

20080214822 - Process for the preparation of a leukotriene antagonist: The present invention relates to a novel process for the preparation of montelukast sodium, a compound of Formula (1b) and precursors thereof. The invention further concerns the free acid of this compound in crystalline form, obtainable for the first time by the new process.... Agent: Scully Scott Murphy & Presser, PC

20080214823 - Preparation of montelukast: A process for preparing amorphous montelukast sodium comprises removing solvent from a solution comprising montelukast sodium using agitated thin film drying.... Agent: Dr. Reddy's Laboratories, Inc.

20080214824 - Process for the preparation of n-(4-piperidinyl)-n-ethyl-phenylacetamides from n-boc-4-oxopiperidine: The present invention concerns a process for the preparation of an N-(4-piperidinyl)-N-ethyl-phenylacetamide of formula (I); wherein R1 and R2 are independently selected from the group comprising: hydrogen, halogen, C1-4 alkyl, C1-4alkoxy, cyano and S(O)2(C1-4 alkyl).... Agent: Morgan Lewis & Bockius LLP

20080214825 - Method for producing substituted halopyridines: Methods for producing substituted halopyridines (II) by reacting a β-hydroxy-y-acyl butyronitrile (I) or a suitable acyl-protected derivative with hydrogen halides, or substances or mixtures that can release hydrogen halides. In the formulae (I) and (II): R, R4 represent H, a linear or branched alkyl group, optionally a substituted aryl group,... Agent: Propat, L.L.C.

20080214826 - Processes for the manufacture of a pyrrolidine-3,4-dicarboxamide derivative: t

20080214827 - Synthesis of cyanoimino-benzoimidazoles: Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.... Agent: Davidson Davidson & Kappel LLC.

20080214828 - Process for production of sulfoxide derivatives or salts thereof in the amorphous state: wherein R1 represents a hydrogen atom, a methoxy group, or a difluoromethoxy group; R2 represents a methyl group or a methoxy group; R3 represents a 3-methoxypropoxy group, a methoxy group, or a 2,2,2-trifluoroethoxy group; R4 represents a hydrogen atom or a methoxy group; and B represents a hydrogen atom, an... Agent: Birch Stewart Kolasch & Birch